In ZINC since | Heavy atoms | Benign functionality |
---|---|---|
October 25th, 2005 | 26 | Yes |
Popular Name: PI-103 PI-103
Find On: PubMed — Wikipedia — Google
CAS Numbers: 371935-74-9 , 371935-74-9; 371935-91-0 , 371935-79-4 , [371935-74-9]
3-(4-Morpholinopyrido[3',2':4,5]furo[3,2-d]pyrimidin-2-yl)phenol
3-(4-Morpholinopyrido[3',2':4,5]furo[3,2-d]pyrimidin-2-yl)phenol hydrochloride
Phenol, 3-[4-(4-morpholinyl)pyrido[3',2':4,5]furo[3,2-d]pyrimidin-2-yl]ml#sthash.FNAnhyNX.dpuf
Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
---|---|---|---|---|---|---|---|---|---|---|
Ref Reference (pH 7) | 2.75 | -6.5 | -13.05 | 1 | 7 | 0 | 84 | 348.362 | 2 | ↓ |
Note Type | Comments | Provided By |
---|---|---|
Purity | 95% | Fluorochem |
Target | DNA-PK, PI3K, mTOR | Selleck Chemicals |
Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
BRAF-1-E | Serine/threonine-protein Kinase B-raf (cluster #1 Of 1), Eukaryotic | Eukaryotes | 2900 | 0.30 | Binding ≤ 10μM |
CLK1-2-E | Dual Specificty Protein Kinase CLK1 (cluster #2 Of 2), Eukaryotic | Eukaryotes | 3900 | 0.29 | Binding ≤ 10μM |
DAPK1-1-E | Death-associated Protein Kinase 1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 2400 | 0.30 | Binding ≤ 10μM |
DAPK2-1-E | Death-associated Protein Kinase 2 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 2700 | 0.30 | Binding ≤ 10μM |
DAPK3-1-E | Death-associated Protein Kinase 3 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 840 | 0.33 | Binding ≤ 10μM |
LIMK2-1-E | LIM Domain Kinase 2 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 3500 | 0.29 | Binding ≤ 10μM |
MRCKA-1-E | Serine/threonine-protein Kinase MRCK-A (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1800 | 0.31 | Binding ≤ 10μM |
MYLK-1-E | Myosin Light Chain Kinase, Smooth Muscle (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1500 | 0.31 | Binding ≤ 10μM |
P3C2B-1-E | Phosphatidylinositol-4-phosphate 3-kinase C2 Domain-containing Beta Polypeptide (cluster #1 Of 1), Eukaryotic | Eukaryotes | 10 | 0.43 | Binding ≤ 10μM |
PK3CA-2-E | PI3-kinase P110-alpha Subunit (cluster #2 Of 2), Eukaryotic | Eukaryotes | 2 | 0.47 | Binding ≤ 10μM |
PK3CB-1-E | PI3-kinase P110-beta Subunit (cluster #1 Of 2), Eukaryotic | Eukaryotes | 3 | 0.46 | Binding ≤ 10μM |
PK3CG-2-E | PI3-kinase P110-gamma Subunit (cluster #2 Of 3), Eukaryotic | Eukaryotes | 250 | 0.36 | Binding ≤ 10μM |
RAF1-1-E | Serine/threonine-protein Kinase RAF (cluster #1 Of 1), Eukaryotic | Eukaryotes | 3700 | 0.29 | Binding ≤ 10μM |
Z103203-1-O | A375 (cluster #1 Of 3), Other | Other | 330 | 0.35 | Functional ≤ 10μM |
Z80224-1-O | MCF7 (Breast Carcinoma Cells) (cluster #1 Of 14), Other | Other | 180 | 0.36 | Functional ≤ 10μM |
Z80682-1-O | A549 (Lung Carcinoma Cells) (cluster #1 Of 11), Other | Other | 540 | 0.34 | Functional ≤ 10μM |
Z81057-1-O | HUVEC (Umbilical Vein Endothelial Cells) (cluster #1 Of 4), Other | Other | 1 | 0.48 | Functional ≤ 10μM |
Z81247-1-O | HeLa (Cervical Adenocarcinoma Cells) (cluster #1 Of 9), Other | Other | 540 | 0.34 | Functional ≤ 10μM |
Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
DAPK3_HUMAN | O43293 | Death-associated Protein Kinase 3, Human | 840 | 0.33 | Binding ≤ 1μM |
P3C2B_HUMAN | O00750 | Phosphatidylinositol-4-phosphate 3-kinase C2 Domain-containing Beta Polypeptide, Human | 10 | 0.43 | Binding ≤ 1μM |
PK3CA_BOVIN | P32871 | PI3-kinase P110-alpha Subunit, Bovin | 3.6 | 0.45 | Binding ≤ 1μM |
PK3CA_HUMAN | P42336 | PI3-kinase P110-alpha Subunit, Human | 3.6 | 0.45 | Binding ≤ 1μM |
PK3CB_HUMAN | P42338 | PI3-kinase P110-beta Subunit, Human | 3 | 0.46 | Binding ≤ 1μM |
PK3CG_HUMAN | P48736 | PI3-kinase P110-gamma Subunit, Human | 250 | 0.36 | Binding ≤ 1μM |
DAPK1_HUMAN | P53355 | Death-associated Protein Kinase 1, Human | 2400 | 0.30 | Binding ≤ 10μM |
DAPK2_HUMAN | Q9UIK4 | Death-associated Protein Kinase 2, Human | 2700 | 0.30 | Binding ≤ 10μM |
DAPK3_HUMAN | O43293 | Death-associated Protein Kinase 3, Human | 840 | 0.33 | Binding ≤ 10μM |
CLK1_HUMAN | P49759 | Dual Specificty Protein Kinase CLK1, Human | 3900 | 0.29 | Binding ≤ 10μM |
LIMK2_HUMAN | P53671 | LIM Domain Kinase 2, Human | 3500 | 0.29 | Binding ≤ 10μM |
MYLK_HUMAN | Q15746 | Myosin Light Chain Kinase, Smooth Muscle, Human | 1500 | 0.31 | Binding ≤ 10μM |
P3C2B_HUMAN | O00750 | Phosphatidylinositol-4-phosphate 3-kinase C2 Domain-containing Beta Polypeptide, Human | 10 | 0.43 | Binding ≤ 10μM |
PK3CA_HUMAN | P42336 | PI3-kinase P110-alpha Subunit, Human | 3.6 | 0.45 | Binding ≤ 10μM |
PK3CA_BOVIN | P32871 | PI3-kinase P110-alpha Subunit, Bovin | 3.6 | 0.45 | Binding ≤ 10μM |
PK3CB_HUMAN | P42338 | PI3-kinase P110-beta Subunit, Human | 3 | 0.46 | Binding ≤ 10μM |
PK3CG_HUMAN | P48736 | PI3-kinase P110-gamma Subunit, Human | 250 | 0.36 | Binding ≤ 10μM |
BRAF_HUMAN | P15056 | Serine/threonine-protein Kinase B-raf, Human | 2300 | 0.30 | Binding ≤ 10μM |
MRCKA_HUMAN | Q5VT25 | Serine/threonine-protein Kinase MRCK-A, Human | 1800 | 0.31 | Binding ≤ 10μM |
RAF1_HUMAN | P04049 | Serine/threonine-protein Kinase RAF, Human | 3700 | 0.29 | Binding ≤ 10μM |
Z103203 | Z103203 | A375 | 330 | 0.35 | Functional ≤ 10μM |
Z80682 | Z80682 | A549 (Lung Carcinoma Cells) | 540 | 0.34 | Functional ≤ 10μM |
Z81247 | Z81247 | HeLa (Cervical Adenocarcinoma Cells) | 540 | 0.34 | Functional ≤ 10μM |
Z81057 | Z81057 | HUVEC (Umbilical Vein Endothelial Cells) | 0.6 | 0.50 | Functional ≤ 10μM |
Z80224 | Z80224 | MCF7 (Breast Carcinoma Cells) | 130 | 0.37 | Functional ≤ 10μM |
Description | Species |
---|---|
ARMS-mediated activation | |
CD28 dependent PI3K/Akt signaling | |
Constitutive PI3K/AKT Signaling in Cancer | |
Costimulation by the CD28 family | |
CREB phosphorylation through the activation of Ras | |
DAP12 signaling | |
Downstream signal transduction | |
Downstream TCR signaling | |
EPHB-mediated forward signaling | |
Frs2-mediated activation | |
G alpha (12/13) signalling events | |
G alpha (q) signalling events | |
G beta:gamma signalling through PI3Kgamma | |
GAB1 signalosome | |
GP1b-IX-V activation signalling | |
GPVI-mediated activation cascade | |
Interleukin receptor SHC signaling | |
Interleukin-3, 5 and GM-CSF signaling | |
MEK activation | |
Nephrin interactions | |
PI-3K cascade | |
PI3K Cascade | |
PI3K events in ERBB2 signaling | |
PI3K events in ERBB4 signaling | |
PI3K/AKT activation | |
PIP3 activates AKT signaling | |
RAF activation | |
RAF phosphorylates MEK | |
Rap1 signalling | |
Regulation of signaling by CBL | |
Role of DCC in regulating apoptosis | |
Role of LAT2/NTAL/LAB on calcium mobilization | |
Role of phospholipids in phagocytosis | |
Sema4D induced cell migration and growth-cone collapse | |
Signaling by constitutively active EGFR | |
Signaling by FGFR mutants | |
Signaling by FGFR1 fusion mutants | |
Signaling by SCF-KIT | |
Signalling to p38 via RIT and RIN | |
Smooth Muscle Contraction | |
Spry regulation of FGF signaling | |
Stimuli-sensing channels | |
Synthesis of PIPs at the plasma membrane | |
Tie2 Signaling | |
VEGFA-VEGFR2 Pathway |
No pre-computed analogs available. Try a structural similarity search.